David H. Weinstein, M.D. is the GI doctor for the Atlanta Braves and has consistently been voted a Top Doctor by his peers from 2012 to present.
Dr. Weinstein joined Metro Atlanta Gastroenterology, LLC on March 1st, 2007. He provides care for adult patients, 18 years of age and older.
Dr. Weinstein is a native of Atlanta completing his undergraduate studies graduating Cum Laude at the University of Georgia where he was also a Phi Beta Kappa. He graduated from Emory University School of Medicine in 1998. In 2001 he completed his residency in Internal Medicine at UNC in Chapel Hill, NC. He is on staff at Saint Joseph’s Hospital.
Dr. Weinstein completed his Gastroenterology Fellowship at UNC in 2004.
Dr. Weinstein has a particular interest in Crohn’s and Colitis. He is active in the Atlanta Chapter of the Crohn’s and Colitis Foundation and serves on their medical advisory board. He performs EGD’s and Colonoscopies. Hear Dr. Weinstein talking with a patient with Crohn’s disease to get an inside look at treating this illness- watch video now.
DR. WEINSTEIN HAS BEEN NAMED RECIPIENT OF 2023 ADULT PREMIER PHYSICIAN BY THE CROHN’S AND COLITIS FOUNDATION.
CLICK BELOW TO DONATE IN HONOR OF DR. WEINSTEIN OR PURCHASE TICKETS TO THE TORCH GALA HONORING DR. WEINSTEIN.
Adenoma detection rate (ADR) is the widely accepted national benchmark on quality for screening colonoscopy. A physician’s adenoma detection rate is the proportion of individuals undergoing a complete screening colonoscopy who have one or more adenomas, or polyps, detected.
Adenoma Detection Rate is critical for a quality colonoscopy and for colon cancer prevention. For every 1 percent increase in a physician’s ADR, a patient’s risk of developing colon cancer over the next year decreases by 3 percent. Doctors who are extremely proficient at finding and removing precancerous polyps have patients who are less likely to get cancer. In addition, the adenoma detection rate was inversely associated with the risks of interval colorectal cancer, advanced-stage interval cancer, and fatal interval cancer. (Source: N Engl J Med 2014; 370:1298-1306)
As you can see from the graphs below, over the last 5-year period Dr. Weinstein’s detection rate far exceeds the national average.
